(Q54077958)

24 May 2018

title

Protein-loaded poly(epsilon-caprolactone) microparticles. II. Muramyl dipeptide for oral controlled release of adjuvant. (English)

1 reference

24 May 2018

author name string

Youan BB

1

1 reference

24 May 2018

Benoit MA

2

1 reference

24 May 2018

Rollmann B

3

1 reference

24 May 2018

Riveau G

4

1 reference

24 May 2018

Gillard J

5

1 reference

24 May 2018

publication date

1 September 1999

1 reference

24 May 2018

Journal of Microencapsulation

published in

1 reference

24 May 2018

volume

16

1 reference

24 May 2018

issue

5

1 reference

24 May 2018

page(s)

601-612

1 reference

24 May 2018

Formulation of vaccine adjuvant muramyldipeptides (MDP). 1. Characterization of amorphous and crystalline forms of a muramyldipeptide analogue

cites work

1 reference

https://api.crossref.org/works/10.1080%2F026520499288799

Eradication of spontaneous metastases and activation of alveolar macrophages by intravenous injection of liposomes containing muramyl dipeptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F026520499288799

Release of human serum albumin from poly(lactide-co-glycolide) microspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F026520499288799

Biodegradable nanocapsules containing a lipophilic immunomodulator: drug retention and tolerance towards macrophages in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F026520499288799

Protein precoating of polylactide microspheres containing a lipophilic immunopotentiator for enhancement of macrophage phagocytosis and activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F026520499288799

The role of adjuvants in retroviral vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F026520499288799

21 January 2018

Identifiers

DOI

10.1080/026520499288799

1 reference

24 May 2018

1 reference

24 May 2018